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SUMMARY
Tuberculosis is emerging/re-emerging in captive elephant populations, where it causes morbidity
and deaths, although no case of TB in wild African elephants has been reported. In this paper
we report the ﬁrst case of fatal TB in an African elephant in the wild. The infection with
Mycobacterium tuberculosis was conﬁrmed by post-mortem and histological examinations of a
female sub-adult elephant aged>12 years that died in Tsavo East National Park, Kenya, while
under treatment. This case is unique in that during its lifetime the elephant had contact with both
humans and wild elephants. The source of the infection was unclear because the elephant could
have acquired the infection in the orphanage or in the wild. However, our results show that wild
elephants can maintain human TB in the wild and that the infection can be fatal.
Key word : Tuberculosis (TB).
Tuberculosis (TB) is an old disease that occurs
worldwide but is mostly endemic in sub-Saharan
Africa, where it continues to threaten public health
and devastate the livestock industry [1, 2]. Bacteria
from the genus Mycobacterium, particularly Myco-
bacterium bovis and M. tuberculosis are the frequent
causal pathogens of animal and human TB, respect-
ively [1]. Epidemiology, prevention and treatment of
TB in humans have been complicated by the upsurge
of the HIV epidemic, and the emergence of multidrug-
resistant strains [2]. Increased interactions between
wild animal reservoirs and humans with their livestock
create opportunities for cross-transmissionofTB [3, 4].
Transmission of TB between wildlife and humans
is commonly reported in captive conditions [5–7],
although infected free-ranging wildlife may cause the
spillover of TB to livestock and eventually to humans.
However, transmission pathways involving wildlife
are neglected and rarely included in the epidemiologi-
cal strategies towards curbing spread of the disease [8].
The disease is now prevalent in free-ranging wildlife
and of concern is the involvement of human TB [4].
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TB is emerging/re-emerging in elephants where it is
associated with the morbidity and death of captive
populations [5, 9]. Occupational risks that require
close and elongated interactions between elephants
and their handlers create the opportunity for bi-
directional transmission of TB, a pathway that intro-
duced the fatal multidrug-resistant strain into an
elephant [10]. Further, elephants infected with human
TB, have been reported to transmit the pathogen to
their human handlers [5], a scenario that has grave
implications for public health [9]. Human TB has only
been detected in domesticated elephants, although the
prevalence of M. tuberculosis in wild elephants has
not been evaluated. Wild animals are likely to acquire
human TB as they scavenge or forage near human
settlements where they may be exposed to TB-
contaminated materials [4]. In Kenya, prevalence of
TB infection in elephants (Loxodonta africana) is
unknown, although there are both captive and wild
populations [20]. Of interest are the domesticated
elephant orphans rescued from the wild and reared by
humans until they are released back into the wild.
Tsavo East National Park is situated in South
Eastern Kenya at latitude 2x 46k 43a S and longitude
38x 46k 18a E. This semi-arid savannah region covers
11747 km2 and is mainly plain grassland at an elev-
ation of 229 m, but the craggy hills and mountains
reach 2438 m. Within this park, is the Voi elephant
stockade, established as an orphanage for rearing
rescued elephant calves. The orphans are released into
the wild through a process of habituation and mixing
with wild elephants, a transition that takes 8–10 years
(www.sheldrickwildlifetrust.org). Rainfall is unpre-
dictable in the park, although long periods of rain are
expected between March and May, while the short
rainy period is between October and December, with
an annual average rainfall of 250–500 mm. The Tsavo
ecosystem which comprises contiguous Tsavo East
and Tsavo West National parks holds the largest
elephant population in Kenya with 10000 animals
according to the 2012 census [11]. Tsavo East is also
home to many small and large herbivores [e.g. impala
(Aepyceros melampus), African buﬀalo (Syncerus caf-
fer), black rhinoceros (Diceros bicornis), hippopota-
mus (Hippopotamus amphibius)] ; carnivores [e.g. lion
(Pathera leo), leopard (Panthera pardus)], and non-
human primates [e.g. baboon (Papio anubis), vervet
monkey (Cercopithecus aethiops)]. There are several
streams that water the area, such as the Mbololo river
and the Athi-Galana river. In recent times, pastoral
communities and their animals [e.g. camels (Camelus
dromedarius), sheep (Ovis aries), goats (Capra hircus),
cattle (Bos taurus)] have moved into the wildlife dis-
persal areas around this park to graze their animals.
This has enhanced contact between wildlife, human,
and livestock, an interaction that has many negative
ramiﬁcations such as frequent human–wildlife con-
ﬂicts, resource scarcity and may potentially allow for
pathogen and vector exchange.
In this short report we describe the case of a female
sub-adult elephant aged >12 years, formerly an or-
phan named ‘Loisaba’. The elephant was originally
rescued as an abandoned calf from the Laikipia re-
gion of Central Kenya. The calf was raised along with
other rescued orphans at the Voi elephant stockade,
located within Tsavo East National Park. Along
with other rehabilitated orphans, Loisaba, then aged
7 years, was released back into the wild within the
Tsavo National Park. Loisaba was in her ﬁfth year in
the wild when gradual loss of body condition was
(a) (b)
Fig. 1 [colour online]. Gross pathological examination. (a) The thin arrow indicates the nodular whitish substance that covers
the cross-section of the left lung and the thick arrow indicates the infected section of the lung. (b) The thick arrow indicates
the remaining apparently normal part of the lung.
observed about 3 months before her death. During
this period, the monitoring team from the stockade
observed that the elephant tended to lag behind
the herd. When the elephant was found isolated from
the herd with a staggering gait, it was rescued and
returned to the stockade for examination and treat-
ment (Supplementary Fig. S1).
The elephant was examined and the following
were noted: general malaise, reluctant to move, loss of
breath, dyspnoea and emaciation. The animal was
tentatively diagnosed as having pneumonia and was
treated with long-acting antibiotics and non-steroidal
anti-inﬂammatory drugs, which were administered
parenterally via intramuscular injections on 25 June
2011. The animal died 2 days later on the night of
27 June 2011 and necropsy was performed on the
morning of 28 June 2011.
A ﬁeld veterinarian performed a general post-
mortem on the animal. Sections of the lungs were then
excised for histology. These samples were frozen and
transported to the Diagnostic Pathology laboratory at
the Institute of Primate Research, Nairobi. At the
laboratory, the lungs were thawed and sliced into thin
sections that were then ﬁxed in 10% neutral buﬀered
formalin and processed using routine histological
techniques. Sections (4- to 5-mm thick) were prepared
from the paraﬃn-embedded specimens, stained with
haematoxylin and eosin and analysedmicroscopically.
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Fig. 2 [colour online]. Histological examination of elephant lung. (a) The thick arrows indicate ﬁbrous encapsulating material.
The thin arrow indicates the characteristic stellate formation of a tubercle. Note the lost architectural pattern of the lung due
to collapsed alveoli and the increased mononuclear inﬁltration. (b) Arrow (A) shows a giant cell in the midst of other
inﬂammatory cells while arrow (B) shows cellular debris in an alveolar (H&E stain,r100).
Fig. 3 [colour online]. An impression smear from a section of the elephant lung showingMycobacterium tuberculosis (arrows)
(Ziehl–Neelsen stain,r1000).
Impression smears from the thawed lung tissue were
also made and acid fast-stained using Ziehl–Neelsen
stain [22].
We observed that the elephant was anaemic as
depicted by paleness of the mucus membranes.
Sub-mandibular lymph nodes were congested and
enlarged. The appearance and texture of the lungs
were altered, with about 85% of both right and left
lobes inﬁltrated with whitish nodules that were un-
even to the touch. The non-caseated parts looked
meaty in appearance due to consolidation (Fig. 1).
Histology of the lungs showed collapsed alveoli, areas
of mononuclear cellular inﬁltration especially plasma
cells and cellular debris encapsulated with ﬁbrous
material (Fig. 2a) and giant cells (Fig. 2b). An im-
pression smear of the lungs showed reddish rods or
dots typical of M. tuberculosis (Fig. 3).
TB is an emerging/re-emerging zoonotic disease
with signiﬁcant risks to livestock, wildlife and public
health. The status of TB in free-ranging elephants
in Kenya and elsewhere is unknown. However, the
detection of human TB in wild mongooses (Mungos
mungo) shows that wild animals can maintain human
TB and demonstrates that increased contact between
humans and wildlife creates an opportunity for inter-
species pathogen exchange [4]. This transmission op-
portunity exists in Africa where 29% of the global
burden and 34% of TB-associated deaths occur [23].
In the present report, the histological and gross
pathology indicate that the elephant had TB infection
caused by M. tuberculosis. This case is unique in that
during its lifetime the elephant had contact with both
humans (orphanage period during the ﬁrst 7 years of
life) and wild elephants (post-release period during
the last 5 years of life), and hence the source of infec-
tion of this elephant is equivocal as it could have ac-
quired it from wild conspeciﬁcs post-release, or from
the orphanage.
This case of fatal TB in a wild African elephant
raises the following questions regarding the epidemi-
ology of TB. (1) ‘Could past years of human contact
have predisposed the elephant to TB?’ If so, then the
elephant had a latent infection for over 5 years in the
wild. (2) ‘Which factors might have triggered clinical
disease? ’ Elephants that acquire human TB in cap-
tivity may maintain latent infection for many years
[13, 14] but when they develop clinical disease they are
either treated or die in captivity. Nevertheless, the
present scenario is diﬀerent in that if the elephant ac-
quired human TB while in contact with humans, upon
release, it carried the risk of spreading the disease
to other wild species or conspeciﬁcs. This suggests
that release of rehabilitated animals, with prolonged
human contact, may act as a conduit for human-
acquired pathogens for wild animal populations. The
period for development of delayed hypersensitivity in
wild animals varies for diﬀerent species and for indi-
vidual animals in a population in which TB has
been diagnosed. This has been observed in captive
elephants in which individuals diﬀered in the
period they harboured latent TB infection [13]. If the
elephant was not infected in the orphanage, then it
must have acquired the disease in the wild.
We therefore recommend that (a) the release of
domesticated elephants into the wild requires eﬃcient
screening for TB, and (b) the status of TB in wild
elephants should be assessed.
Our results show that whatever the source of in-
fection, an African elephant living in the wild can
harbour latent TB infection, which can become clini-
cal and cause death.
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